Lewis D A, Sherman B M
J Clin Endocrinol Metab. 1984 Mar;58(3):458-62. doi: 10.1210/jcem-58-3-458.
Controversy still exists regarding the role of serotonin in the regulation of ACTH secretion. We gave normal men three oral doses (0.5, 1.0, and 1.5 mg/kg) of fenfluramine, a serotonin-releasing agent and uptake inhibitor, and a corresponding placebo. There was a significant dose-dependent stimulatory effect of fenfluramine on both ACTH and cortisol levels. After the highest dose of fenfluramine, mean ACTH and cortisol levels increased from 20.8 pg/ml and 7.3 micrograms/dl to 35.5 pg/ml and 15.1 micrograms/dl, respectively. In a separate study, normal men were pretreated with cyproheptadine, a serotonin antagonist, before the administration of fenfluramine. Cyproheptadine did not significantly alter basal ACTH or cortisol levels, but it did blunt the responses of both hormones to fenfluramine. Cyproheptadine pretreatment did not alter plasma levels of fenfluramine. These findings support a stimulatory role for serotonin in the regulation of ACTH secretion in man.
关于血清素在促肾上腺皮质激素(ACTH)分泌调节中的作用,目前仍存在争议。我们给正常男性口服三种剂量(0.5、1.0和1.5毫克/千克)的芬氟拉明,这是一种血清素释放剂和摄取抑制剂,同时给予相应的安慰剂。芬氟拉明对ACTH和皮质醇水平均有显著的剂量依赖性刺激作用。在服用最高剂量的芬氟拉明后,平均ACTH和皮质醇水平分别从20.8皮克/毫升和7.3微克/分升增加到35.5皮克/毫升和15.1微克/分升。在另一项研究中,正常男性在服用芬氟拉明之前先用血清素拮抗剂赛庚啶进行预处理。赛庚啶并未显著改变基础ACTH或皮质醇水平,但它确实减弱了两种激素对芬氟拉明的反应。赛庚啶预处理并未改变血浆中芬氟拉明的水平。这些发现支持了血清素在人类ACTH分泌调节中具有刺激作用的观点。